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Exposures to persistent organic compounds 
and resulting health effects have been the sub-
ject of many scientific papers and global trea-
ties. Of special concern are the potential effects 
of these chemicals on the fetus and infant. The 
ability to assess infant exposures to environ-
mental chemicals via breast-feeding is crucial 
for developing a complete picture of early-life 
exposures to those chemicals. Conventional 
wisdom regarding lactational exposures to per-
sistent organic chemicals presumes a decline 
in concentrations over the course of lacta-
tion [U.S. Environmental Protection Agency 
(EPA) 2003] and that the origin of those 
chemicals lay in a mother’s cumulative expo-
sure over her lifetime (Miyata et al. 2006). 
Two important implications stemming from 
these lines of thought are that assessments of 
childhood exposures during the first year(s) of 
life should incorporate decreasing breast milk 
concentrations over the course of lactation 
and that there is little a breast-feeding mother 
can currently do to reduce her infant’s chemi-
cal exposures via breast-feeding.
The supposition that elimination of per-
sistent organic chemicals via breast-feeding 
results in a decrease in breast milk concentra-
tions during lactation derives from research 
that has measured levels of various chemicals 
in breast milk at different times postpartum. 
In fact, much of the past literature on this 
topic has shown relatively consistent results: 
levels decreasing over the course of lactation, 
albeit with different studies reporting different 
rates of elimination (LaKind et al. 2001). It 
has been suggested that about 60% of lipids 
in breast milk originate from the mother’s 
adipose tissue (Hachey et al. 1987), generally 
lending support to the concept that the pre-
dominant origin of lipophilic persistent chem-
icals in milk could be via remobilization of 
those chemicals stored in the mother’s adipose 
tissue. Consequently, as a woman breast-feeds, 
her stores of lipids and lipid-associated envi-
ronmental chemicals are mobilized, and her 
accumulated levels would therefore decrease 
as the chemicals are excreted with breast milk. 
In fact, it seemed that the key piece of missing 
information for robust exposure assessments 
of the breast-fed infant was the quantification 
of chemical-specific rates of decrease in con-
centration. In the absence of that information, 
models of infant exposures via breast-feeding 
have made assumptions about rates of decrease 
in breast milk concentrations over time (e.g., 
50% over 6 months) (LaKind et al. 2000). 
For a complete assessment of infant expo-
sures, in addition to being able to quantify 
changes in concentration over lactation, 
information on the initial concentrations of 
chemicals in breast milk is needed. Surveillance 
biomonitoring using human milk is convenient 
and gives information on levels of chemicals in 
the mother and infant exposures, but can also 
heighten concerns that breast-feeding may be 
unsafe. In addition, the availability of labora-
tories capable of performing analysis of breast 
milk for environmental chemicals is limited. 
Thus, if another biological matrix could be 
used as a surrogate for breast milk, then valu-
able exposure information would be obtained 
without negatively affecting breast-feeding rates 
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Ba c k g r o u n d: Conventional wisdom regarding exposures to persistent organic chemicals via breast-
feeding assumes that concentrations decline over the course of lactation and that the mother’s body 
burden reflects her cumulative lifetime exposure. Two important implications stemming from 
these lines of thought are, first, that assessments of early childhood exposures should incorporate 
decreasing breast milk concentrations over lactation; and, second, that there is little a breast-feeding 
mother can do to reduce her infant’s exposures via breast-feeding because of the cumulative nature 
of these chemicals.
oBjectives: We examined rates of elimination and milk/serum partition coefficients for several 
groups of persistent organic chemicals.
Me t h o d s : We collected simultaneous milk and blood samples of 10 women at two times postpar-
tum and additional milk samples without matching blood samples.
re s u l t s: Contrary to earlier research, we found that lipid-adjusted concentrations of polybromi-
nated diphenyl ethers, polychlorinated biphenyls, polychlorinated dibenzo-p-dioxins and furans, 
and organochlorine pesticides in serum and milk do not consistently decrease during lactation and 
can increase for some women. Published research has also suggested an approximate 1:1 milk/serum 
relationship (lipid adjusted) on a population basis for 2,3,7,8-tetrachlorodibenzo-p-dioxin; however, 
our results suggest a more complex relationship for persistent, lipophilic chemicals with the milk/
serum relationship dependent on chemical class.
co n c l u s i o n s: Decreases in concentration of lipophilic chemicals on a lipid-adjusted basis during 
lactation should no longer be assumed. Thus, the concept of pumping and discarding early milk as 
means of reducing infant exposure is not supported. The hypothesis that persistent lipophilic chemi-
cals, on a lipid-adjusted basis, have consistent concentrations across matrices is likely too simplistic. 
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or requiring increased laboratory capacity. A 
multitude of studies have examined blood levels 
of lipophilic persistent chemicals, including the 
National Health and Nutrition Examination 
Survey, a nationwide study conducted every 2 
years in the United States [Centers for Disease 
Control and Prevention (CDC) 2005]. The 
determination of milk:serum partitioning coef-
ficients that are stable over the duration of lac-
tation could allow for the use of blood levels 
as a surrogate for estimating infant exposures 
from mother’s milk. Although a constant rela-
tionship for chemical concentrations in human 
tissues and fluids on a lipid-adjusted basis 
has been hypothesized based on research into 
lipid-adjusted serum:adipose tissue ratios for 
2,3,7,8-tetrachlorodibenzo-p-dioxin (Patterson 
et al. 1988) and an initial review of earlier data 
suggested that on a population basis, breast 
milk lipid concentrations of persistent lipo-
philic compounds generally reflect blood lipid 
levels, albeit with significant variations in these 
ratios among individuals (Aylward et al. 2003), 
a more complex chemical- and tissue-specific 
relationship is emerging (Wittsiepe et al. 
2007). 
In this study, we sought to quantify rates 
of elimination and milk:serum partition coef-
ficients for several groups of persistent organic 
chemicals by collecting simultaneous milk and 
blood samples from women at two times post-
partum and additional milk samples without 
matching blood samples. This is the first study 
to provide data based on simultaneous sam-
pling of breast milk and blood at separate times 
during lactation. We analyzed serum and milk 
for 17 polychlorinated dibenzo-p-dioxins and 
furans (PCDDs/PCDFs), 36 polychlorinated 
biphenyls (PCBs), 9 persistent chlorinated 
organic pesticides, and 10 polybrominated 
diphenyl ethers (PBDEs). 
Methods
The study was conducted with the approval 
of the Milton S. Hershey Medical Center 
Human Subjects Protection Office and com-
plied with all applicable requirements of U.S. 
regulations. The CDC Institutional Review 
Board relied on that review under a coop-
erative research agreement. All study subjects 
gave informed consent. 
Study participants. A convenience cohort 
of 10 study participants was drawn from the 
population of women seeking prenatal care 
and women whose children receive pediatric 
care at the Penn State College of Medicine. 
Enrollment guidance was generally in accor-
dance with the World Health Organization 
(WHO) guidelines for the study of persistent, 
organic compounds in human milk (WHO 
2007); however, exclusive breast-feeding was 
not required for this investigation because of 
the limited number of women in the United 
States who exclusively breast-feed for extended 
periods of time. In addition, participants were 
eligible for inclusion if they had lived in the 
Lancaster County/Harrisburg area for the pre-
vious 3 (as opposed to 10) years. 
Questionnaires were administered at the 
beginning and end of each mother’s participa-
tion in the study, with personal, demographic, 
lifestyle, and dietary information obtained. In 
addition, at the time of maternal milk and 
blood collection, we collected data on each 
infant’s age, weight, and history of intake of 
infant formula or other foods. 
Maternal milk and serum sampling. 
Participants washed their hands and breast 
prior to manually expressing the sample, with 
warm water and disposable breast pads used 
for cleaning, if desired. Milk was expressed 
into clean containers that were prescreened for 
cross-contaminants, including the analytes of 
interest. Participants provided milk samples 
at 1, 2, and 3 months postpartum and at the 
cessation of lactation. Approximately 30 mL 
(1 oz) milk per sampling collection event per 
mother was collected.
Blood was sampled by a trained phlebot-
omist at the same time (within 1 hr) of the 
milk sampling during the first and last milk 
donations. Approximately 15 mL serum was 
needed for the analytical component of this 
research, necessitating the collection of five 
tubes of 10 mL whole blood each. Serum from 
clotted blood was separated by centrifugation 
and stored in amber glass vials. Milk and serum 
specimens were stored frozen until they were 
shipped on dry ice via next-day delivery to the 
CDC. On arrival at the CDC, milk and blood 
specimens were stored at –70°C until analysis. 
Analytical method. Serum samples (2 mL) 
were fortified with 13C-labeled internal stan-
dards and formic acid and water for protein 
denaturation and diluted using a Gilson 215 
liquid handler (Gilson Inc., Middleton, WI) 
for automation (Sjödin et al. 2004a). The 
samples were extracted by solid phase extrac-
tion (SPE) using the Rapid Trace modular 
SPE work station (Caliper Life Sciences, 
Hopkinton, MA) for automation. Removal 
of coextracted lipids was performed on a 
silica:silica/sulfuric acid column using the 
modular SPE work station for automation. 
Milk samples (1 mL) were processed using 
solid phase dispersion on Hydromatrix (Varian 
Inc., Walnut Creek, CA) and automatic forti-
fication with 13C-labeled internal standards 
using the liquid handler (Sjödin et al. 2004b). 
The samples were then dried using pressur-
ized nitrogen (8 kPa) and extracted by elution 
with dichloromethane using the modular SPE 
workstation for automation. The lipid concen-
tration of the entire sample was determined 
gravimetrically using an AX105 Delta Range 
analytical balance (Mettler Toledo, Columbus, 
OH). Removal of coextracted lipids was per-
formed using the same method as for serum.
Analytical determination of serum and 
milk PBDEs, PCBs, and organochlorine 
pesticides was performed by gas chroma-
tography-isotope dilution high-resolution 
mass spectrometry (GC-IDHRMS) employ-
ing a MAT95XP (ThermoFinnigan MAT, 
Bremen, Germany) instrument. The serum 
lipid concentration was determined using 
commercially available test kits from Roche 
Diagnostics Corp. (Indianapolis, IN) for the 
quantitative determination of total triglyc-
erides (product no. 011002803-0600) and 
total cholesterol (product no. 011573303-
0600) (Phillips et al. 1989). Final determina-
tions were made on a Hitachi 912 Chemistry 
Analyzer (Hitachi, Tokyo, Japan). Total 
serum lipid concentration was estimated from 
the concentration of total cholesterol and 
triglycerides. Every analytical run contained 
24 unknown samples, three blanks and three 
quality control (QC) samples. The CV for 
the serum method is approximately 2‒4% for 
QCs spiked at 500 pg/mL serum. The CV for 
the milk method is approximately 10% (the 
analysis of QC samples spiked at 500 pg/mL 
milk corresponds to approximately 10 ng/g 
lipid; hence, the QC samples were spiked at 
an environmentally relevant concentration). 
For PCDDs/Fs and coplanar PCBs, serum 
(10 g) or milk samples (5 g) were spiked with 
13C internal standards. We calculated serum 
total lipids using an enzymatic summation 
method (Phillips et al. 1989). Milk samples 
were extracted and lipid was determined gravi-
metrically. Serum and milk sample extracts were 
diluted with hexane, and the cleanup procedure 
followed the method of Turner et al. (1997). 
The concentrations of PCDDs/Fs and coplanar 
PCBs in serum and milk were determined by 
GC-IDHRMS (Patterson et al. 1987).
Data analysis. Depuration. For a given 
chemical, to determine whether there was sys-
tematic evidence of a decrease (or increase) 
in serum concentration over time, we used a 
paired two-sample sign test. For seven of the 
study participants, two serum samples taken 
approximately 30 days postpartum and at the 
end of lactation (56‒280 days postpartum) 
were available. The test statistic was the num-
ber of mothers of the seven whose serum con-
centrations decreased from the initial sampling 
to final sampling. Similarly, for testing the 
hypothesis of an increase in serum concentra-
tion, an analogous count was used. The test 
statistics for increases and decreases in con-
centration do not necessarily sum to seven, 
because in some cases the concentration for a 
given chemical did not change. Concentrations 
below the method detection limit for the 
chemical were excluded from the analysis.
For the milk data, we used the samples 
collected 1 and 3 months postpartum for 
analysis to maintain consistency of the time 
period examined. Nine of the 10 participants Chemical concentrations during lactation
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breast-fed for the 3-month time period. An 
analysis similar to that described for serum was 
performed.
Milk:serum partitioning. We focused 
on milk:serum ratios from samples collected 
1 month postpartum, as end-of-study collection 
times varied according to the participant’s dura-
tion of lactation. In addition, because results 
near the limit of detection (LOD) are subject 
to greater uncertainty, we limited the analyses 
to chemicals that were detected in all partici-
pants for serum and milk [bromodiphenyl ether 
(BDE) 47 and 100; hexachlorobenzene (HCB); 
trans-nonachlor; 1,1-dichloro-2,2-bis(p-chloro-
phenyl)ethylene (p,p´-DDE); 1,1,1-trichloro-
2,2-bis(p-chlorophenyl)ethane (p,p´-DDT); 
PCBs 74, 99, 118, 126, 138-158, 146, 153, 
170, 180, and 187; 1,2,3,6,7,8-hexachloro-
dibenzo-p-dioxin (HxCDD); 1,2,3,4,6,7,8-
hepta  chloro  dibenzo-p-dioxin (HpCDD); 
octachlorodibenzo-p-dioxin (OCDD); and 
1,2,3,4,6,7,8-heptachlorodibenzofuran 
(HpCDF)]. For the 20 chemicals, we used 
least squares to fit a line through each set of 
10 milk:serum pairs (from each of the 10 par-
ticipants) and then used these fits to test 
whether the intercept was significant. Only one 
intercept was significant (BDE-100, p = 0.02). 
Therefore, we fit lines without intercepts for 
each chemical as
  milk = slope of line × serum.  [1]
In other words, the slope of the line can be 
interpreted as an estimate of the milk:serum 
ratio. We also used a line fit on a log scale, 
that is,
  log(y) = log(b) + log(x),  [2]
and then estimated log(b) to be the average of 
the difference log(y) ‒ log(x) (i.e., taking an 
estimated b to be the geometric mean of all of 
the ratios y/x). 
Results
Ten mothers participated in the study. [See 
Supplemental Material, Table 1, for demo-
graphic and personal data; available online 
(doi:10.1289/ehp.0900876.S1 via http://
dx.doi.org/)]. Seventeen serum samples and 
35 milk samples were collected. Information 
on the timing of collection of milk and blood 
for the 10 participants is given in Table 1. 
Median concentrations in milk and serum 
lipids and percent detects for all chemicals 
detected in at least 50% of serum and milk 
samples are given in Table 2. Measurements 
below the LOD were set equal to reported 
LOD for each sample. Units are nanograms 
per gram lipid except for PCDDs/Fs and PCBs 
126 and 169 (picograms per gram lipid).
Depuration. Serum. First and last serum 
samples were used to determine whether 
changes in concentrations of PCDDs/Fs, 
PCBs, PBDEs, or organochlorine pesticides 
were observed. For some of the mothers a time 
period of almost 1 year was available (Table 1); 
we therefore assumed that any potential 
long-term decreases (or increases) in serum 
concentrations would be observable. None of 
the chemical concentrations decreased over the 
course of lactation for all mothers. Specifically, 
when a decrease in serum concentration of a 
chemical was observed, it was never observed 
for more than five of the mothers (p = 0.227). 
Table 1. Timing of collection of milk and blood samples. 
Participant no.
First collection (date) 
[infant age, days]
Second collection 
(days after  
first collection)
Third collection 
(days after 
second collection) 
Fourth collection 
(days after  
third collection)
30 8/17/04 – M,S [35] 41 days – M   36 days – M,S –
1 9/13/04 – M,S [37] 28 days – M 35 days – M 129 days – M,S
2 11/30/04 – M,S [34] 28 days – M 28 days – M 149 days – M,S
3 12/27/04 – M,S [30] 32 days – M 35 days – M 56 days – M,S
4a 1/25/05 – M,S [31] – – –
5 1/20/05 – M,S [31] 42 days – M 33 days – M 232 days – M,S
7 6/30/05 – M,S [31] 33 days – M 31 days – M 280 days – M,S
8b 7/26/05 – M,S [29] 29 days – M 34 days – M 277 days – M,S
9c 8/19/05 – M,S [33] 39 days – M 29 days – M 266 days – M
10d 10/13/05 – M,S [30] 35 days – M 35 days – M –
Abbreviations: M, milk; S, serum. 
aOne collection only because of illness. bInformation available for month and year only. cUnable to draw blood at end of 
study. dLost contact at end of study.
Table 2. Median concentrations in milk and serum lipids and percent detects for all chemicals detected 
in at least 50% of serum and milk samples.
Chemical
Median 
(ng/g lipid milk)
No. 
(milk)
% Detect 
milk
Median 
(ng/g lipid serum)
No. 
(serum)
% Detect 
serum
BDE-047 26 35 100 15.5 17 100
BDE-100 4 35 100 2.4 17 100
BDE-153 3.5 35 100 4 17 58.8
HCB 8.05 35 100 6.9 17 88.2
Oxychlordane 13.65 35 94.3 5.1 17 82.4
t-Nonachlor 14.5 35 100 5.8 17 94.1
p,p´-DDE 142 35 100 79.3 17 100
p,p´-DDT 5.46 35 97.1 2.5 17 94.1
Mirex 0.84 35 91.4 0.8 17 76.5
PCB-105 1.65 35 100 0.8 17 88.2
PCB-118 6.51 35 100 4 17 100
PCB-138-158 20.47 35 100 13.2 17 100
PCB-146 2.4 35 97.1 1.7 17 100
PCB-153 22.85 35 100 15.9 17 100
PCB-156 3 35 97.1 2.2 17 70.6
PCB-170 4.28 35 100 3.9 17 100
PCB-177 0.86 35 77.1 0.6 17 52.9
PCB-178 0.97 35 85.7 0.8 17 70.6
PCB-180 10.49 35 100 9.8 17 100
PCB-183 1.55 34 88.2 1.2 17 94.1
PCB-187 3.61 35 97.1 2.7 17 100
PCB-194 1.46 35 85.7 1.7 17 94.1
PCB-196-203 1.63 35 94.3 1.9 17 94.1
PCB-201 1.49 35 88.6 1.7 17 88.2
PCB-206 0.5 35 80 1 17 88.2
PCB-28 2.12 35 65.7 0.9 17 58.8
PCB-66 0.95 34 94.1 0.6 17 58.8
PCB-74 6.4 35 100 3.5 17 100
PCB-99 5.47 35 100 3.1 17 100
Chemical
Median 
(pg/g lipid milk)
No. 
(milk)
% Detect 
milk
Median 
(pg/g lipid serum)
No. 
(serum)
% Detect 
serum
1,2,3,6,7,8-HxCDD 11.40 33 100 15.00 17 100
1,2,3,4,6,7,8-HpCDD 10.87 34 100 22.60 17 100
OCDD 70.00 34 100 211.0 17 100
2,3,4,7,8-PnCDF 3.81 34 88.2 4.20 17 94.1
1,2,3,4,7,8-HxCDF 1.92 33 93.9 3.30 17 64.7
1,2,3,6,7,8-HxCDF 1.63 33 72.7 3.60 17 76.5
1,2,3,4,6,7,8-HpCDF 2.32 34 97.1 7.40 17 100
OCDF 0.17 34 50 5.30 17 94.1
PCB-126 12.19 34 100 12.00 17 100
PCB-169 7.36 34 100 8.10 17 94.1
Abbreviations: HxCDF, hexachlorodibenzofuran; OCDF, octachlorodibenzofuran; PnCDF, pentachlorodibenzofuran. LaKind et al.
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However, of the 74 chemicals for which 
there are sufficient concentration data, for 
12 of those chemicals there were either five 
(BDE-100; p,p´-DDE; PCBs 153, 170, 187, 
201) or six (PCBs 180, 183, 194, 196-203; 
1,2,3,4,6,7,8-HpCDD; 1,2,3,4,6,7,8-Hp-
CDF) mothers for whom an increase in con-
centration was seen (p = 0.063), although not 
always for the same mother(s).
Milk. Milk samples were available from 
nine of the mothers at 1 and 3 months post-
partum. None of the chemicals showed a 
decrease in concentration in milk for more 
than six mothers, and none increased in 
concentration for all nine mothers. For one 
chemical (p,p´-DDE), eight of the mothers 
(p = 0.02) showed an increase in concentra-
tion in month 3 compared with month 1. For 
nine chemicals (BDE-153; trans-nonachlor; 
PCBs 74, 99, 105, 146, 153, 180, 187), seven 
of the mothers (p = 0.09) showed an increase 
in concentration over the same time frame. 
Also, not all of the chemicals with increased 
concentrations from months 1‒3 post  partum 
showed an increase at month 2; thus, the 
overall direction of the change from month 
to month is not necessarily consistent. Using 
a chi-square test for comparing variances, we 
established that many of the apparent differ-
ences between measurements over months 1 
and 2 and months 1 and 3 for individual par-
ticipants cannot be explained by laboratory 
measurement error. For examples highlighting 
some of these complexities for DDE and BDE 
47, see Figure 1 and Supplemental Material, 
Figure 2 [available online (doi:10.1289/
ehp.0900876.S1)].
Milk:serum partitioning. For 15 of the 
chemicals [BDEs 47 and 100; HCB; trans-
nonachlor; p,p´-DDE; p,p´-DDT; and nine 
PCBs (118, 138-158, 146, 153, 170, 180, 
187, 74, 99)], the slopes of the lines repre-
senting the ratio of lipid-adjusted milk:serum 
values are not typically equal to 1 as hypoth-
esized and are statistically significantly larger 
than 1 (Figure 2), although the fitted slopes 
are within a factor of 3 to the hypothesized 1:1 
correspondence [see Supplemental Material, 
Table 2, available online (doi:10.1289/
ehp.0900876.S1)]. The relationship for these 
chemicals as a group is
milk (lipid adjusted) =  
  1.74 × serum (lipid adjusted)   [3] 
  R2 = 0.98.
However, for four chemicals (1,2,3,6,7,8-
HxCDD; 1,2,3,4,6,7,8-HpCDD; OCDD; 
1,2,3,4,6,7,8-HpCDF), the slopes of the 
lines representing the ratio of lipid-adjusted 
milk:serum values were statistically signifi-
cantly less than 1 (Figure 3). For these chemi-
cals, the fitted slopes are approximately within 
an order of magnitude of the hypothesized 1:1 
correspondence [see Supplemental Material, 
Table 2, available online (doi:10.1289/
ehp.0900876.S1)]. The relationship for these 
chemicals is
milk (lipid adjusted) =  
  0.33 × serum (lipid adjusted)   [4] 
  R2 = 0.91.
For PCB-126, the slope is not signifi-
cantly different from 1.0.
The same results were obtained for the 
slopes for the two sets of chemicals using the 
log scale approach.
The hypothesis of a consistent relationship 
between milk and serum concentrations on 
a lipid-adjusted basis would be undermined 
should another physicochemical property 
have a stronger effect than the lipophilicity of 
the chemical. Linear regression of log Kow or 
molecular weight and slopes of milk:serum 
relationships gave poor correlations (R2 
= 49%, R2 = 12%, respectively). However, 
after separating the chemicals by class (pesti-
cides, dioxin-like compounds, and PCBs) and 
conducting a similar analysis, it appears that 
molecular weight explains some of the relation-
ship between chemical levels in milk and serum 
[see Supplemental Material, Figure 2, avail-
able online (doi:10.1289/ehp.0900876.S1)]. 
Likewise, using this approach, log Kow gave 
similar results in terms of slope versus log Kow 
relationships, but it was not as good a predictor 
for the pesticides and PCBs (data not shown). 
The analysis of the data focused on devel-
oping generalizable relationships across classes 
of persistent, lipophilic chemicals. Degree of 
chlorination across chemical classes was not 
significantly associated with milk:serum par-
titioning. However, for the non-dioxin-like 
PCBs with at least 50% of the values above 
LOD, degree of chlorination was strongly 
associated with partitioning (R2 = 0.88). 
Discussion and Conclusions
Our goals in this study were to characterize 
a) changes in breast milk concentrations of 
several groups of persistent organic chem-
icals during lactation, and b) the relation-
ship between lipid-adjusted concentrations 
of those chemicals in serum and breast milk. 
Past published research has suggested both 
a decrease in concentration over the course 
of lactation and an approximate 1:1 lipid-
adjusted milk:serum relationship. However, 
our results more closely parallel recent studies 
on depuration of chemicals by lactation that 
show variable changes in milk concentrations 
over lactation. Our results also suggest a more 
complex milk:serum relationship 
Depuration. Our results show that lipid-
adjusted concentrations of PBDEs, PCBs, 
PCDDs/Fs, and organochlorine pesticides 
in serum and milk do not reliably decrease 
over the course of lactation and may increase 
for some women. This is in contrast with a 
more recent study on depuration of PBDEs 
and PCBs in milk (Hooper et al. 2007), 
where a small but consistent decrease in milk 
concentration (12‒18% for PBDEs and 4% 
for PCBs) was observed over 6 months of 
  breast-feeding. 
In our study, breast milk concentrations 
for many of the chemicals increased between 
months 1 and 3 postpartum for most moth-
ers. Similarly, serum concentrations increased 
for many of the chemicals between sampling 
at 1 month postpartum and end of lactation. 
However, examination of specific chemicals 
suggests a more complicated picture. For 
example, for months 1‒3 postpartum, con-
centrations of p,p´-DDE decreased in one 
mother’s breast milk by 27% but increased 
in the milk of the other eight mothers by 
4‒37% (Figure 1). For BDE-153, concentra-
tions in milk decreased over the same time 
frame in two of the mothers (by 7% and 35 
%) but increased in six mothers by 2‒116%. 
Concentrations of PCB-153 decreased in two 
mothers (3% and 33%) and increased in the 
others (5‒53%). Thus, the trend of the chem-
ical concentration is mother dependent and 
does not appear to be related to her initial 
concentration. 
Similar complexities in changes in chemi-
cal concentration over time were reported by 
Jin and Su (2005), who observed a decline in 
average toxic equivalents (TEQs) in milk over 
Figure 1. Lipid-adjusted concentrations of DDE (ng/g lipid) over the duration of lactation for the seven par-
ticipants with first and last collections for both milk and serum. Each line represents an individual. 
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the first 30 days of lactation but with concen-
trations of certain congeners increasing during 
that time. Miyata et al. (2001) also reported 
that PCDDs/Fs in milk did not decline in a 
consistent manner: Some participants’ levels 
declined whereas others increased postpartum.
This prompts the question: What factors 
determine whether concentrations increase, 
decrease, or remain approximately the 
same over lactation? Two factors, postpar-
tum weight loss and current diet, have been 
hypothesized and are discussed here in the 
context of our results. 
Postpartum weight loss. If a mother expe-
riences substantial weight loss postpartum, 
it has been hypothesized that the remobi-
lization of adipose tissue could produce an 
increase in circulating levels of previously 
stored lipophilic chemicals, resulting in an 
increase (or less of a decrease) in breast milk 
levels (LaKind 2007; Lovelady et al. 1999). It 
has also been suggested that mobilization of 
stored chemicals in adipose tissue can enhance 
their enterohepatic clearance (Jandacek and 
Tso 2001).
A limited number of studies have exam-
ined the influence of postpartum weight 
change on environmental chemical concen-
trations in breast milk (reviewed in Table 3, 
LaKind 2007). Except for a study of one 
woman by Vaz et al. (1993), no effect of post-
partum weight loss was observed. 
In this current study, weight and body 
mass index (BMI) data were collected at 
1 month postpartum but not at the end of 
the study period. Thus, we cannot evaluate 
the relationship between change in weight 
or BMI and concentrations of chemicals 
in breast milk in the postpartum period. 
However, if it is hypothesized that weight 
loss would result in mobilization of adipose 
tissue and associated lipophilic chemicals, 
then we should notice consistency in increases 
in lipid-adjusted levels of highly lipophilic 
chemicals in the serum and milk compart-
ments for individual women. Our data do not 
demonstrate this consistency. Focusing on 
chemicals that are tightly regulated (banned 
or have strict controls on emissions) and are 
thought to have similar routes of exposure 
(principally via diet), it is clear that within 
one mother, changes (increase vs. decrease) in 
concentrations of these chemicals over time 
are not consistent. For example, whereas one 
participant (no. 30) showed increases in all 
chemicals (including PBDEs) for which levels 
were above the detection limit for both sam-
pling periods (1 and 3 months postpartum for 
milk and serum), for the other participants, 
some chemical concentrations increased while 
other decreased during the same period. 
Participant no. 5’s serum and milk lipid-ad-
justed concentrations of 1,2,3,4,6,7,8-Hp-
CDD increased over lactation, but serum 
and milk OCDD decreased. The direction of 
change in concentration was matrix depen-
dent for HCB, PCB-170, PCB-126, and 
1,2,3,4,6,7,8-HpCDF. In another participant 
(no. 7), serum levels for most of the chemi-
cals decreased, but again, several of the milk 
concentrations increased, and several chemi-
cals did not change in a consistent direction 
for both matrices. Perhaps the most incon-
sistent was participant no. 8, whose serum 
levels decreased for almost all of the chemicals 
studied (from 1 to 12 months postpartum), 
but whose breast milk levels increased (from 
months 1 to 3 postpartum) for most of those 
chemicals. Other participants had similar 
incongruities in their serum and milk data. 
The lack of consistency in increase or 
decrease in concentrations across chemicals 
and matrices makes it less likely that weight 
change is a dominant contributing factor to 
levels of chemicals in breast milk, but it does 
suggest that the controlling factors are likely 
numerous and complex. 
Diet. Dietary lipids are thought to con-
tribute approximately 29% of breast milk 
lipid (Hachey et al. 1987), and for many per-
sistent organic compounds, diet is consid-
ered the principal route of exposure. (The 
exception may be the PBDEs, for which diet 
and household dust are both thought to be 
significant contributors.) It has been assumed 
that because many of the persistent organic 
chemicals are legacy chemicals (that is, they 
are no longer in production and their cur-
rent releases are negligible), levels in women 
today can be attributed principally to lifetime 
accumulation. This implies that there are no 
actions that breast-feeding women can take 
to reduce their breast-fed infants’ exposures. 
However, recent research on within-day vari-
ability in dioxin breast milk concentrations 
and correlation with diet and fasting suggests 
that diet during lactation may play an impor-
tant role in influencing levels of persistent 
organic compounds in breast milk (Miyata 
et al. 2001, 2006). Specifically, breast milk 
(30 samples over 5 days) and samples of 
Figure 2. Relationship between lipid-adjusted milk:serum concentrations (ng/g 
lipid) of two PBDEs (BDE 47, BDE 100); four pesticides/metabolites (HCB, trans-
nonachlor, p,p´-DDE, p,p´-DDT); and nine PCBs (118, 138-158, 146, 153, 170, 180, 
187, 74, 99). The red line shows the relationship “serum concentration = milk 
concentration.” The blue line is the least-squares fit for the data in this study.
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Figure 3. Relationship between lipid-adjusted milk:serum concentrations (pg/g 
lipid) for three PCDDs (1,2,3,6,7,8-HxCDD, 1,2,3,4,6,7,8-HpCDD, OCDD) and 
1,2,3,4,6,7,8-HpCDF. The red line shows the relationship “serum concentration 
= milk concentration.” The blue line is the least-squares fit for the data in this 
study. 
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diet (over 3 days) were obtained from one 
mother, and breast milk from two additional 
mothers was obtained over 5 days, 3 days of 
which the two mothers fasted (Miyata et al. 
2006). Levels of dioxin TEQs in the first 
mother’s diet and her breast milk exhibited 
large fluctuations over the 3 days. Dioxins in 
breast milk also decreased substantially dur-
ing fasting. The short time frame over which 
the Miyata et al. (2006) research was con-
ducted further suggests that diet, rather than 
weight change, influenced levels in milk. The 
plausibility of current intake of one group of 
chemicals (PCDDs/Fs) via current diet being 
associated with levels in breast milk has been 
described (LaKind 2007). In this study, we 
did not measure dietary levels of the chemi-
cals of interest and so cannot form conclu-
sions regarding dietary intake. However, the 
data showing variations, including increases, 
in chemical concentrations over lactation do 
not rule out a dietary influence.
Milk:serum partitioning. Should con-
sistent, stable, lipid-based, chemical-specific 
milk:serum partitioning factors be deter-
mined, these could allow for the use of serum 
measurements for estimating levels in milk 
and for estimating infant exposures from 
breast-feeding. Some studies have found lip-
id-adjusted levels of PCDDs, PCDFs, and 
PCBs to be approximately equivalent in 
serum and milk [reviewed by Aylward et al. 
(2003)]. However, other studies have found 
more complex relationships. For example, 
Wittsiepe et al. (2004) reported that some 
PCDDs/Fs and PCBs preferentially partition 
into lipids of one matrix over another. Factors 
that may influence partitioning of these com-
pounds include differences in lipophilicity and 
molecular size and weight, which can affect 
their membrane permeability (LaKind 2007; 
Wittsiepe et al. 2004) and degree of chlori-
nation (Patterson et al. 1989). Suzuki et al. 
(2005) reported relative concentrations of 
lipid-adjusted PCDD TEQs in the following 
maternal compartments: placenta > maternal 
blood > breast milk > adipose tissue > cord 
blood. For lipid-adjusted PCDFs, a differ-
ent order was observed: placenta > maternal 
blood > cord blood > breast milk > adipose 
tissue. The authors suggest that different 
chemical groups may have different affinities 
for specific tissue types. A statistically signifi-
cant correlation was found between concen-
trations in adipose tissue and breast milk for 
the sum of seven PBDEs, but with congener-
specific differences (Antignac et al. 2009), for 
example, for BDEs 99 and 153. Jaraczewska 
et al. (2006) did not find significant correla-
tions between lipid-adjusted breast milk and 
maternal serum concentrations for organo-
chlorine pesticides (HCB, p,p´-DDE, p,p´-
DDT) or PCBs (118, 138, 153, 170, 180) in 
22 women. However, reanalyzing their data 
excluding one participant whose values were 
substantially higher than those of the other 
participants, we find milk:serum relationships 
from their study consistent with our results 
for PCBs 138, 153, 170, 180, and p,p´-DDE.
Our results showed no clear relation-
ship between log Kow and lipid-adjusted 
milk:serum ratios for the 17 chemicals with 
sufficient data above the LOD and for which 
Kow values are available. However, the deter-
mination of Kow for extremely lipophilic 
chemicals is difficult, and reported results can 
cover a large range of values. In fact, for many 
of the chemicals in this study, Kow values 
spanning more than one order of magnitude 
were found in the published literature. 
Within the group of chemicals with 
milk:serum ratios < 1 (the PCDDs/Fs), there 
appears to be preferential partitioning into 
milk for lower weight and smaller Kow chemi-
cals. Within the group of chemicals with 
milk:serum ratios > 1, milk:serum ratios for 
PCBs were inversely correlated with molecu-
lar weight, whereas organochlorine pesticides 
were positively correlated with molecular 
weight. A correlation was observed between 
degree of chlorination and milk:serum ratios 
for PCBs, with the lower chlorinated PCBs 
preferentially partitioning into milk, as was 
observed by Wittsiepe et al. (2007). 
Three important conclusions from the 
results of this study, and supported by previ-
ous research, can be drawn:
•	Our	results	suggest	that	elimination	of	
chemicals via lactation is complex and that 
decreases in concentrations of lipophilic 
chemicals over the course of lactation should 
no longer be assumed. This is true for all 
of the chemical classes assessed, including 
PCDDs/Fs, PCBs, organochlorine pesti-
cides, and PBDEs. Because no decrease in 
concentration over time can be assumed, 
the concept of pumping and discard-
ing early milk (or “pump and dump”) for 
breast-feeding mothers as a means of reduc-
ing infant exposure (Hooper et al. 2007; 
Steingraber 2002) is not supported. This 
conclusion also has important implications 
for the conduct of research on infant expo-
sure and risk assessments, where declines 
in breast milk concentrations of these 
chemicals over lactation have been assumed. 
Because some of the percent changes during 
lactation were > 300%, falling outside the 
range of what would be considered minimal 
change, studies that incorporate analyses of 
diet and dust, as well as weight changes over 
lactation, are needed to better parse out the 
various factors that may influence chemical 
concentrations in breast milk over lactation. 
•	If current diet is a significant source of per-
sistent environmental chemicals in breast 
milk, this implies that new mothers may be 
able to take actions that could reduce infant 
exposure. However, this is a complex issue, 
as one food group that may contain higher 
levels of one class of the persistent chemi-
cals (e.g., PCBs in fish) might be replaced 
with another food group containing other 
chemicals that may be transferred to breast 
milk (e.g., dioxins in dairy products). Further 
study focusing on measurements of chemicals 
in diet and changes in milk concentration is 
warranted before specific dietary advice can 
be given.
•	The hypothesis that concentrations of persis-
tent lipophilic chemicals on a lipid-adjusted 
basis would have consistent relationships 
across matrices is likely too simplistic. This 
study revealed two distinct milk:serum 
ratios, one > 1, and one < 1. Whether these 
differences would have a substantial impact 
on infant exposure assessments is less clear. 
At present, we suggest that the milk:serum 
ratios given in this paper be used to evaluate 
infant exposure if only serum data are avail-
able. We further recommend that additional 
studies that include a larger cohort be con-
ducted to confirm these results. Additional 
components of future research that might 
elucidate these findings include repeated 
measures of BMI and assessment of post-
pregnancy changes in size of body compart-
ments such as fat and muscle.
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